Compton Wealth Advisory Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-954
Closed -$352K 90
2024
Q4
$352K Hold
954
0.09% 86
2024
Q3
$496K Hold
954
0.13% 79
2024
Q2
$517K Hold
954
0.14% 75
2024
Q1
$495K Hold
954
0.14% 74
2023
Q4
$450K Hold
954
0.14% 65
2023
Q3
$415K Hold
954
0.14% 72
2023
Q2
$424K Sell
954
-116
-11% -$53.5K 0.14% 73
2023
Q1
$492K Sell
1,070
-86
-7% -$40.9K 0.17% 67
2022
Q4
$593K Buy
1,156
+44
+4% +$22.3K 0.23% 65
2022
Q3
$505K Sell
1,112
-289
-21% -$138K 0.21% 66
2022
Q2
$676K Sell
1,401
-376
-21% -$186K 0.29% 64
2022
Q1
$873K Buy
+1,777
New +$812K 0.34% 60

Other funds holding ELV

Compton Wealth Advisory Group's ELV Position: Q1 2025 in Review

Compton Wealth Advisory Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 954 shares — an estimated $352K sold.

Compton Wealth Advisory Group first reported a position in ELV in Q1 2022 and held it in 12 quarters. The position peaked at $873K in Q1 2022. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Compton Wealth Advisory Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Compton Wealth Advisory Group sold 954 Elevance Health shares in Q1 2025, an estimated $352K.
  • Compton Wealth Advisory Group first reported a position in Elevance Health in Q1 2022 and held it in 12 quarters.
  • Compton Wealth Advisory Group's Elevance Health position peaked at $873K in Q1 2022.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Compton Wealth Advisory Group's 13F filing for Q1 2025, filed 29 Apr 2025.